Monday, March 20, 2017 5:57:20 PM
1- The results are postive and will warrent moving the product to market.
2- The product will be on the market at some point in Q2 and will begin producing revenue.
3- There are positive treatment results for other illnesses.
Though we all expected and assumed this it is good to hear confirmation though entirely vague on purpose I'm sure.
This is now my thoughts and should be taken as such.
I'm encouraged, not hearing word for nearly a month is a long time when seeing such volent swings. I would expect to hear efficacy results soon with news or shortly after the other applications. Additionally the EFT should be launching within the next 2 weeks. (Again this is only my thoughts on timing but next Wednesday is 6 weeks from announcement and that is the typical timeframe) Couple all this with the conferences this week and next. I could see news droping from several catalyst in a tight sequence which could push PPS rather high.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM